Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-15 4:30 pm Purchase | 2025-01-10 | 13G | Pacira BioSciences, Inc. PCRX | MILLENNIUM MANAGEMENT LLC | 2,338,369 5.100% | 2,338,369 (New Position) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Pacira BioSciences, Inc. PCRX | VANGUARD GROUP INC | 5,098,424 10.980% | 173,229 (+3.52%) | Filing History |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 8,113,714 17.500% | 862,806 (+11.90%) | Filing History |
| 2023-02-14 1:31 pm Sale | 2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX | MACQUARIE GROUP LTD | 2,037,049 4.440% | -2,168,473 (-51.56%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX | VANGUARD GROUP INC | 4,925,195 10.730% | 259,240 (+5.56%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 7,250,908 15.800% | 429,390 (+6.29%) | Filing History |
| 2022-03-02 11:54 am Sale | 2022-02-28 | 13G | Pacira BioSciences, Inc. PCRX | BAILLIE GIFFORD & CO | 2,170,707 4.840% | -184,533 (-7.83%) | Filing History |
| 2022-02-14 10:05 am Purchase | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | MACQUARIE GROUP LTD | 4,205,522 9.440% | 1,452,880 (+52.78%) | Filing History |
| 2022-02-10 5:22 pm Sale | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | RENAISSANCE TECHNOLOGIES LLC | 1,849,197 4.150% | -775,862 (-29.56%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | VANGUARD GROUP INC | 4,665,955 10.470% | 298,689 (+6.84%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 6,821,518 15.300% | 0 (Unchanged) | Filing History |
| 2022-01-27 09:49 am Purchase | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BAILLIE GIFFORD & CO | 2,355,240 5.290% | 2,355,240 (New Position) | Filing History |
| 2022-01-26 09:16 am Sale | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 6,821,518 15.300% | -278,329 (-3.92%) | Filing History |
| 2021-02-12 08:40 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | MACQUARIE GROUP LTD | 2,752,642 6.340% | 680,468 (+32.84%) | Filing History |
| 2021-02-10 12:04 pm Purchase | 2020-03-04 | 13G | Pacira BioSciences, Inc. PCRX | RENAISSANCE TECHNOLOGIES LLC | 2,625,059 6.040% | 2,625,059 (New Position) | Filing History |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | VANGUARD GROUP INC | 4,367,266 10.050% | 22,712 (+0.52%) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 7,099,847 16.300% | 95,348 (+1.36%) | Filing History |